BillionToOne Expands Its Leadership in Hemolytic Disease of the Fetus and Newborn (HDFN) and Extends Fetal Antigen Testing to Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) ...
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced a new policy for commercial coverage of its cfDNA Fetal RhD ...
Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...
Kindly let me know whether there are any reports/research into incidences or relative risks of Rh alloimmunization in subsequent pregnancies (especially third) in an Rh D-negative G3P2002 with 2 ...
When Charles Cantor and Dennis Lo flew to Pattaya, Thailand in late 2002 to attend a conference, neither man knew they would end up collaborating on a blood test that could one day reduce reliance on ...
What is genetic testing? It refers to medical testing to identify changes within chromosomes, genes or proteins encoded by these genes. The purpose is to confirm or exclude a genetic disorder, or to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results